Bryan T. Baldasare

Bryan T. Baldasare, listed as finance chief, appears in our data through filings on Meridian Bioscience Inc shares, published by SEC (Form 4). We count 18 filings; the first trade dates from 16 September 2019 and the latest from 15 December 2021.

Market trades split into 2 purchases (€12k) and 2 sales (€473k). The net balance comes to €460k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 10 share grants and 3 option exercises. In 2021 alone, the filings show no purchases and 2 sales.

The latest filing, published on 22 December 2021, reports a share grant of €32k in Meridian Bioscience Inc. The clock since the last published purchase (11 March 2020) now reads 2,434 days. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.